NO20053991L - Piperazin-2-karboksamidderivater - Google Patents
Piperazin-2-karboksamidderivaterInfo
- Publication number
- NO20053991L NO20053991L NO20053991A NO20053991A NO20053991L NO 20053991 L NO20053991 L NO 20053991L NO 20053991 A NO20053991 A NO 20053991A NO 20053991 A NO20053991 A NO 20053991A NO 20053991 L NO20053991 L NO 20053991L
- Authority
- NO
- Norway
- Prior art keywords
- piperazine
- carboxamide
- labor
- dysmenorrhea
- prophylaxis
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D231/00—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings
- C07D231/02—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings
- C07D231/10—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D231/12—Heterocyclic compounds containing 1,2-diazole or hydrogenated 1,2-diazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/16—Amides, e.g. hydroxamic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
- A61P15/06—Antiabortive agents; Labour repressants
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
- C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
- C07D233/56—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms or radicals containing only hydrogen and carbon atoms, attached to ring carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
- C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
- C07D241/04—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D249/00—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
- C07D249/02—Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
- C07D249/08—1,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Endocrinology (AREA)
- Reproductive Health (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Gynecology & Obstetrics (AREA)
- Pregnancy & Childbirth (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03003422 | 2003-02-14 | ||
| PCT/EP2004/050093 WO2004071390A2 (fr) | 2003-02-14 | 2004-02-06 | Derives de piperazine-2-carboxamide |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| NO20053991L true NO20053991L (no) | 2005-08-26 |
Family
ID=32864935
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| NO20053991A NO20053991L (no) | 2003-02-14 | 2005-08-26 | Piperazin-2-karboksamidderivater |
Country Status (10)
| Country | Link |
|---|---|
| US (1) | US8404690B2 (fr) |
| EP (1) | EP1592389B1 (fr) |
| JP (1) | JP4825664B2 (fr) |
| AT (1) | ATE429228T1 (fr) |
| AU (1) | AU2004212335A1 (fr) |
| CA (1) | CA2513716A1 (fr) |
| DE (1) | DE602004020734D1 (fr) |
| ES (1) | ES2324535T3 (fr) |
| NO (1) | NO20053991L (fr) |
| WO (1) | WO2004071390A2 (fr) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1511488B1 (fr) | 2002-06-12 | 2013-05-22 | Symphony Evolution, Inc. | Inhibiteurs humains d'adam 10 |
| US7754722B2 (en) * | 2002-09-20 | 2010-07-13 | Merck Serono Sa | Piperazine derivatives and methods of use |
| PT1558582E (pt) | 2003-07-22 | 2006-05-31 | Arena Pharm Inc | Derivados de diaril- e aril-heteroaril-ureia como moduladores do receptor de serotonina 5-ht2a uteis para a profilaxia e tratamento de desordens relacionadas com o mesmo |
| US7713973B2 (en) | 2004-10-15 | 2010-05-11 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| US8119655B2 (en) | 2005-10-07 | 2012-02-21 | Takeda Pharmaceutical Company Limited | Kinase inhibitors |
| US8017612B2 (en) | 2006-04-18 | 2011-09-13 | Japan Tobacco Inc. | Piperazine compound and use thereof as a HCV polymerase inhibitor |
| US7943622B2 (en) | 2006-06-06 | 2011-05-17 | Cornerstone Therapeutics, Inc. | Piperazines, pharmaceutical compositions and methods of use thereof |
| EP2044038B1 (fr) * | 2006-06-06 | 2014-07-02 | Cornerstone Therapeutics Inc. | Nouvelles pipérazines, compositions pharmaceutiques et procédés d'utilisation de celles-ci |
| SG175609A1 (en) | 2006-10-09 | 2011-11-28 | Takeda Pharmaceutical | Kinase inhibitors |
| EP2254564A1 (fr) | 2007-12-12 | 2010-12-01 | Glaxo Group Limited | Associations contenant de la 3-phenylsulfonyl-8-piperazinyl-1yl-quinoline |
| US20110021538A1 (en) | 2008-04-02 | 2011-01-27 | Arena Pharmaceuticals, Inc. | Processes for the preparation of pyrazole derivatives useful as modulators of the 5-ht2a serotonin receptor |
| US9126946B2 (en) | 2008-10-28 | 2015-09-08 | Arena Pharmaceuticals, Inc. | Processes useful for the preparation of 1-[3-(4-bromo-2-methyl-2H-pyrazol-3-yl)-4-methoxy-phenyl]-3-(2,4-difluoro-phenyl)urea and crystalline forms related thereto |
| JP6902466B2 (ja) * | 2014-11-07 | 2021-07-14 | ザ リージェンツ オブ ザ ユニバーシティ オブ ミシガン | ミオカルディン関連転写因子および血清応答因子（ｍｒｔｆ／ｓｒｆ）媒介性遺伝子転写の阻害剤ならびにその使用方法 |
| RU2017145976A (ru) | 2015-06-12 | 2019-07-15 | Аксовант Сайенсиз Гмбх | Производные диарил- и арилгетероарилмочевины, применимые для профилактики и лечения нарушения поведения во время REM-фазы сна |
| KR20180064373A (ko) | 2015-07-15 | 2018-06-14 | 엑소반트 사이언시즈 게엠베하 | 신경퇴행성 질환과 관련된 환각의 예방 및 치료에 유용한 5-ht2a 세로토닌 수용체의 조절자로서의 다이아릴 및 아릴헤테로아릴 우레아 유도체 |
| WO2019104011A1 (fr) * | 2017-11-21 | 2019-05-31 | Biomarin Pharmaceutical Inc. | Inhibiteurs de la céramide galactosyltransférase pour le traitement de maladies |
| WO2020028221A1 (fr) * | 2018-07-30 | 2020-02-06 | Biomarin Pharmaceutical Inc. | Inhibiteurs de la céramide galactosyltransférase pour le traitement d'une maladie |
| WO2021037699A1 (fr) * | 2019-08-26 | 2021-03-04 | Société des Produits Nestlé S.A. | Myo-inositol et prévention de la naissance prématurée |
| WO2021037698A1 (fr) * | 2019-08-26 | 2021-03-04 | Société des Produits Nestlé S.A. | Myo-inositol et prévention la rpmat |
| WO2023215205A1 (fr) * | 2022-05-06 | 2023-11-09 | Merck Sharp & Dohme Llc | Agonistes du récepteur de l'orexine |
| WO2024107615A1 (fr) * | 2022-11-17 | 2024-05-23 | Merck Sharp & Dohme Llc | Agonistes du récepteur de l'orexine |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6450818A (en) | 1987-08-20 | 1989-02-27 | Tsumura & Co | Prostaglandin f2alpha-inhibitor |
| US6271201B1 (en) * | 1993-07-15 | 2001-08-07 | Board Of Regents, The University Of Texas System | Methods for the selective regulation of placental prostanoids and inhibition of labor using IGF-I |
| TW472047B (en) | 1994-02-04 | 2002-01-11 | Merck & Co Inc | Process for making HIV protease inhibitors |
| US5612484A (en) * | 1995-05-18 | 1997-03-18 | Merck & Co., Inc. | Process for making HIV protease inhibitors |
| EP1095936B1 (fr) * | 1995-12-08 | 2004-11-24 | Agouron Pharmaceuticals, Inc. | Intermédiaires servant à la préparation d' inhibiteurs de métalloproteinases |
| DE69926078T2 (de) * | 1998-12-23 | 2006-04-20 | Schering Corp. | Farnesyl-protein transferase inhibitoren |
| WO2000077519A1 (fr) * | 1999-06-15 | 2000-12-21 | Aventis Pharmaceuticals Products Inc. | Synthese en phase solide de derives de diazacycloalkylcarboxy n,n-disubstitues |
| WO2002026720A2 (fr) * | 2000-09-29 | 2002-04-04 | Millennium Pharmaceuticals, Inc. | INHIBITEURS DE FACTOR Xa A BASE DE PIPERAZINE |
| AU2002248322B2 (en) | 2001-01-24 | 2005-06-09 | The Arizona Board Of Regents, On Behalf Of, The University Of Arizona | Methods for screening for substances which inhibit FP prostanoid receptor interaction with a compound having PGF2alphaalphaactivity and methods of treating cancer |
| US7754722B2 (en) | 2002-09-20 | 2010-07-13 | Merck Serono Sa | Piperazine derivatives and methods of use |
-
2004
- 2004-02-06 WO PCT/EP2004/050093 patent/WO2004071390A2/fr active Application Filing
- 2004-02-06 US US10/545,296 patent/US8404690B2/en not_active Expired - Fee Related
- 2004-02-06 AU AU2004212335A patent/AU2004212335A1/en not_active Abandoned
- 2004-02-06 ES ES04708776T patent/ES2324535T3/es not_active Expired - Lifetime
- 2004-02-06 CA CA002513716A patent/CA2513716A1/fr not_active Abandoned
- 2004-02-06 EP EP04708776A patent/EP1592389B1/fr not_active Expired - Lifetime
- 2004-02-06 JP JP2006502009A patent/JP4825664B2/ja not_active Expired - Fee Related
- 2004-02-06 AT AT04708776T patent/ATE429228T1/de not_active IP Right Cessation
- 2004-02-06 DE DE602004020734T patent/DE602004020734D1/de not_active Expired - Lifetime
-
2005
- 2005-08-26 NO NO20053991A patent/NO20053991L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2324535T3 (es) | 2009-08-10 |
| EP1592389B1 (fr) | 2009-04-22 |
| ATE429228T1 (de) | 2009-05-15 |
| JP4825664B2 (ja) | 2011-11-30 |
| AU2004212335A1 (en) | 2004-08-26 |
| US8404690B2 (en) | 2013-03-26 |
| DE602004020734D1 (de) | 2009-06-04 |
| WO2004071390A3 (fr) | 2004-12-23 |
| CA2513716A1 (fr) | 2004-08-26 |
| US20070142391A1 (en) | 2007-06-21 |
| WO2004071390A2 (fr) | 2004-08-26 |
| AU2004212335A8 (en) | 2004-08-26 |
| JP2006517566A (ja) | 2006-07-27 |
| EP1592389A2 (fr) | 2005-11-09 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NO20053991L (no) | Piperazin-2-karboksamidderivater | |
| EA201000563A1 (ru) | Триазолпиридиновые ингибиторы 11-бета- гидроксистероид - дегидрогеназы типа i | |
| EA200401270A1 (ru) | Тиазолидинкарбоксамидные производные как модуляторы рецептора простагландина f | |
| TW200714589A (en) | Phenylacetamides suitable as protein kinase inhibitors | |
| DE60204322D1 (de) | Stickstoffmonoxid bildende zusammensetzungen zur behandlung von nagelbettinfektionen | |
| NO20054905L (no) | 2-acylamino-4-fenyltiazolderivater, fremgangsmate for deres fremstilling og anvendelse av de samme som i terapeutika | |
| CY1113736T1 (el) | Ετεροαρυλ-ουριες και η χρηση τους ως ενεργοποιητες γλυκοκινασης | |
| MY140031A (en) | Carbonyl compounds | |
| GEP20084551B (en) | 4-phenylamino-quinazolin-6-yl-amides | |
| ECSP088358A (es) | Tratamiento y profilaxis de microangiopatías | |
| BRPI0606740A2 (pt) | compostos de bis arila e heteroarila substituìdas como antagonistas de 5ht2a seletivos | |
| MXPA05013536A (es) | Derivados de etinilprolina. | |
| NO20074941L (no) | Anvendelse av diosmetinforbindelser i behandlingen og forebyggingen av trombotiske patologier | |
| NO20050063L (no) | 2-heteroaryl karboksamider | |
| ECSP055844A (es) | Nuevos compuestos triciclicos | |
| WO2003106450A8 (fr) | Phenylaminopyrimidines et leur utilisation en tant qu'inhibiteurs de la rho-kinase | |
| BRPI0519267A2 (pt) | derivado de quinolina, seu uso, produÇço e medicamento contendo o mesmo | |
| ATE349448T1 (de) | Pyrazol-3,4-d-pyrimidinderivate und ihre verwendung bei der behandlung von h.pylori- infektionen | |
| ATE429916T1 (de) | Verwendung von sulfonamid-derivaten bei der behandlung von adipositas oder zur verringerung der nahrungsaufnahme | |
| BR0209541A (pt) | Uso das imidazotriazinonas 2-fenil-substituìdas | |
| TW200609222A (en) | Diazole derivatives | |
| UA85676C2 (en) | Carbonyl compounds | |
| NO20053876D0 (no) | Karbonylaminosubstituerte acylfenylurederivater, fremgangsmate for deres fremstilling samt anvendelse derav | |
| ATE371662T1 (de) | Siliziumverbindungen und deren verwendung | |
| EA200601456A1 (ru) | Способ получения пирролидиноксимов |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CREP | Change of representative |
Representative=s name: ONSAGERS AS, POSTBOKS 6963 ST OLAVS PLASS, 0130 OS |
|
| FC2A | Withdrawal, rejection or dismissal of laid open patent application |